艾曲波帕和大剂量地塞米松作为新诊断原发性免疫血小板减少症儿童的一线治疗药物

{"title":"艾曲波帕和大剂量地塞米松作为新诊断原发性免疫血小板减少症儿童的一线治疗药物","authors":"Monika Richert-Przygonska, Dominika Kołuda, Mariusz Wysocki","doi":"10.5603/ahp.98322","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":"92 23","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Eltrombopag and high-dose dexamethasone as first-line treatment in children with newly diagnosed primary immune thrombocytopenia\",\"authors\":\"Monika Richert-Przygonska, Dominika Kołuda, Mariusz Wysocki\",\"doi\":\"10.5603/ahp.98322\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":35805,\"journal\":{\"name\":\"Acta Haematologica Polonica\",\"volume\":\"92 23\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Haematologica Polonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/ahp.98322\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Haematologica Polonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/ahp.98322","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}